Clinical trial NCT02560194 - References

Colorectal Cancer — Evaluation of Flexible Sigmoidoscopy Screening as an Adjunct to the National FOBT Screening Programme in Scotland

Citation(s)

•   Atkin WS, Cuzick J, Northover JM, Whynes DK
  Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993 Mar 20;341(8847):736-40.
•   Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators
  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010 May 8;375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X. Epub 2010 Apr 27.
•   Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS; International Colorectal Cancer Screening Network
  Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008 Mar 15;122(6):1357-67.
•   Gray M, Pennington CR
  Screening sigmoidoscopy: a randomised trial of invitation style. Health Bull (Edinb). 2000 Mar;58(2):137-40.
•   Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM
  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472-7.
•   Hewitson P, Glasziou P, Watson E, Towler B, Irwig L
  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008 Jun;103(6):1541-9. doi: 10.1111/j.1572-0241.2008.01875.x. Epub 2008 May 13. Review.
•   Hoff G, Grotmol T, Skovlund E, Bretthauer M; Norwegian Colorectal Cancer Prevention Study Group
  Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009 May 29;338:b1846. doi: 10.1136/bmj.b1846.
•   Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ
  Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Eur J Cancer. 2010 Jul;46(11):2059-66. doi: 10.1016/j.ejca.2010.03.022. Epub 2010 Jun 4.
•   Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ
  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089.
•   Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O
  Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467-71.
•   Leslie A, Carey FA, Pratt NR, Steele RJ
  The colorectal adenoma-carcinoma sequence. Br J Surg. 2002 Jul;89(7):845-60. Review.
•   Lindholm E, Brevinge H, Haglind E
  Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg. 2008 Aug;95(8):1029-36. doi: 10.1002/bjs.6136.
•   Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F
  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365-71. Erratum in: N Engl J Med 1993 Aug 26;329(9):672.
•   McCaffery K, Wardle J, Nadel M, Atkin W
  Socioeconomic variation in participation in colorectal cancer screening. J Med Screen. 2002;9(3):104-8.
•   McDonald PJ, Strachan JA, Digby J, Steele RJ, Fraser CG
  Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer. Clin Chem Lab Med. 2011 Dec 7;50(5):935-40. doi: 10.1515/CCLM.2011.815.
•   Robb K, Power E, Kralj-Hans I, Edwards R, Vance M, Atkin W, Wardle J
  Flexible sigmoidoscopy screening for colorectal cancer: uptake in a population-based pilot programme. J Med Screen. 2010;17(2):75-8. doi: 10.1258/jms.2010.010055.
•   Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, Ederle A, Fantin A, Ferrari A, Fracchia M, Ferrero F, Gasperoni S, Recchia S, Risio M, Rubeca T, Saracco G, Zappa M; SCORE3 Working Group-Italy
  Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007 Jun;132(7):2304-12. Epub 2007 Mar 21.
•   Steele RJ, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C
  Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen. 2010;17(2):68-74. doi: 10.1258/jms.2010.009120.
•   Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser CG
  Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut. 2012 Apr;61(4):576-81. doi: 10.1136/gutjnl-2011-300535. Epub 2011 Sep 19.
•   Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, Mowat NA, Wilson JA, Kenicer M, Carey FA, Fraser CG
  Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut. 2009 Apr;58(4):530-5. doi: 10.1136/gut.2008.162883. Epub 2008 Nov 26.
•   van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E
  Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.
•   Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM
  Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ. 1998 Jul 18;317(7152):182-5.

Evaluation of Flexible Sigmoidoscopy Screening as an Adjunct to the National FOBT Screening Programme in Scotland - A Random Evaluation

Details for clinical trial NCT02560194